Suda Pharmaceuticals Ltd, formerly Suda Limited, is a drug delivery company, which is engaged in pharmaceutical development of drug delivery technology, and medical devices and consumables distribution. Its segments are Suda, Westcoast Surgical & Medical Supplies (Westcoast), Malaria Research Company (MRC) and Other. The Suda segment is engaged in research and development to create new human pharmaceutical products by combining drugs with delivery technologies. The Westcoast segment is engaged in sales and logistics operation for medical devices and consumables. The MRC segment is pharmaceutical development segment for the treatment of malaria, including ArTiMist project. ArTiMist is a sublingual spray for the treatment of Plasmodium falciparum severe pediatric malaria. Its other pipeline of products includes Zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its development stage products include orals sprays for the treatment of migraine headache and erectile dysfunction.